Table 6.
Posts ranked in the top 5 for likes and reposts, paraphrased and in chronological ordera.
| Paraphrased posts in chronological order | Like count and rank | Repost count and rank |
| I am thrilled to share exciting news. The first patient has received a dose in the phase 1 trial of Moderna’s mRNA-1644, an HIV vaccine candidate, which utilizes the same mRNA technology as our COVID-19 vaccines! (January 27, 2022) | 18,895; third | 10,572; first |
| We are witnessing the development of an HIV vaccine within our lifetimes. How amazing is that? (January 28, 2022) | 102,843; first | 3881; fourth |
| It’s astonishing that some people are opposed to vaccinations, when Covid vaccines have paved the way for HIV vaccine trials. (January 29, 2022) | 32,115; second | 4370; second |
| I have some exciting news to share. The first patient has received a dose in the phase 1 trial of Moderna’s and National Institutes of Health HIV trimer vaccine candidate, mRNA-1574, which utilizes the same mRNA technology as our COVID-19 vaccines! (March 21, 2022) | 7056; fifth | 1224 |
| Many medical and pharmaceutical achievements including HIV vaccine in progress. What an incredible time to be living in!” (June 3, 2022) | 5034 | 2144; fifth |
| I am overjoyed to share exciting news. Despite being in an early phase 1 trial, results for HIV vaccine candidate eOD-GT8 60mer have revealed 97% of participants (with only one exception) produced an antibody response against HIV! (December 3, 2022) | 18,109; fourth | 3906; third |
aRanks beyond the fifth were not indicated.